GL Biochem (Shanghai): difference between revisions
Diff·revision 18 → 19·18:17, 2 Sep 2024
Difference between revision 18 and revision 19 of GL Biochem (Shanghai). 3 lines changed; the page grew by 336 bytes.
| Revision 18 — 07:02, 29 Aug 2024 DefinedTermDov (talk) fix hyphenation per PP:MOS 4,964 bytes ±0 | Revision 19 — 18:17, 2 Sep 2024 LotTraceLuka (talk) replace bare ref with full citation 5,300 bytes +336 | ||
|---|---|---|---|
| 27 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | 27 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. |
| 28 | 28 | ||
| + | 29 | == Operations and documentation practice == | |
| + | 30 | The organisation's described activity is [[Custom peptide synthesis|custom synthesis]] to specification and supply of protected amino acid derivatives and coupling reagents — the inputs to [[Solid-phase peptide synthesis|solid-phase synthesis]] rather than its retail output.{{r|selfpub}} | |
| + | 31 | ||
| 29 | == References == | 32 | == References == |
| 30 | {{reflist}} | 33 | {{reflist}} |